Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi

Articolo

Data di Pubblicazione:

2016

Citazione:

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi / Sacchi, Stefano; Marcheselli, Raffaella; Bari, Alessia; Buda, Gabriele; Molinari, Anna Lia; Baldini, Luca; Vallisa, Daniele; Cesaretti, Marina; Musto, Pellegrino; Ronconi, Sonia; Specchia, Giorgina; Silvestris, Franco; Guardigni, Luciano; Ferrari, Angela; Chiapella, Annalisa; Carella, Angelo Michele; Santoro, Armando; Di Raimondo, Francesco; Marcheselli, Luigi; Pozzi, Samantha. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 101:5(2016), pp. e196-e199. [10.3324/haematol.2015.139329]

Abstract:

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

Tipologia CRIS:

Articolo su rivista

Keywords:

Efficacy; Indolent; Lenalidomide; Non-follicular lymphoma; Recurrent; Rituximab; Safety; Hematology

Elenco autori: